Á¦ 29ȸ ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-02-17
±³À°ÀÏÀÚ : 2024-02-17
±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ °¡¾ß±ÝȦ
±³À°ÁÖÁ¦ : Á¦ 29ȸ ´ëÇÑÇ÷¾×ÇÐȸ AML/MDS ¿¬±¸È¸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : AML/MDS¿¬±¸È¸
´ã´çÀÚ : Á¤¼¼¿µ
¿¬¶ôó : 02-533-1408
À̸ÞÀÏ : ksh.amlmds.wp@gmail.com
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 17ÀÏ °¡¾ß±ÝȦ 10:00~10:40 Myeloid malignancies / Co-operativity in the pathogenesis °íÁ¤¼÷(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 02¿ù 17ÀÏ °¡¾ß±ÝȦ 10:40~11:20 Epigenetics & chromatin mechanisms / post-translational mechanisms À¯Àç¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02¿ù 17ÀÏ °¡¾ß±ÝȦ 11:20~12:00 Multi-omics driven precision hematology ÀÌ¿µÀº(¼¿ïÀÇ´ë)
½Ä»ç 02¿ù 17ÀÏ °¡¾ß±ÝȦ 12:00~13:00 Á¡½É½Ä»ç ( )
±³À°½Ã°£ 02¿ù 17ÀÏ °¡¾ß±ÝȦ 13:00~13:40 Mitochondria & metabolism / Biology behind therapy resistance ÃÖÇõÁø(°æºÏÀÇ´ë)
±³À°½Ã°£ 02¿ù 17ÀÏ °¡¾ß±ÝȦ 13:40~14:20 Stem cell biology / Gene regulation of differentiation ÀÌÁ¾¹Ì(°¡Å縯ÀÇ´ë)
ÈÞ½Ä 02¿ù 17ÀÏ °¡¾ß±ÝȦ 14:20~14:40 È޽Ľð£ ( )
±³À°½Ã°£ 02¿ù 17ÀÏ °¡¾ß±ÝȦ 14:40~15:20 Optimized therapy of AML / Remarkable abstracts about AML ±è¹ÌÈñ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 02¿ù 17ÀÏ °¡¾ß±ÝȦ 15:20~16:00 Treatment Options of R/R AML / Remarkable abstracts about R/R AML ÀÌÁ¾Çõ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02¿ù 17ÀÏ °¡¾ß±ÝȦ 16:00~16:40 Personalized therapy of MDS / Remarkable abstracts about MDS À̼¼¿ø(ÀÌÈÀÇ´ë)